Leukopenic and Lethal Effects of Slime from Acinetobacter calcoaceticus

Similar documents
EXPERIMENTAL SALMONELLOSIS

F. NAMAVAR", J. DE GRAAFF~, C. DE WITH$ AND D. M. MACLAREN"

Rifampin Resistance. Charlottesville, Virginia i0w organisms in Trypticase soy broth (BBL Microbiology

CHAPTER 8 ANTIBACTERIAL ACTIVITY OF THE CRUDE ETHANOLIC EXTRACT AND THE ISOLATED COMPOUNDS FROM THE STEM OF COSTUS IGNEUS

Urinary tract infection, Urinary pathogens.

Influence of Water Diuresis on Antimicrobial

Enhancing Effect on Alkalinization of the Medium

Clinical experience with ceftazidime in urology in Japan

Key words: G-CSF, immunocompromised host, pyelonephritis, active oxygen

Affinity of Doripenem and Comparators to Penicillin-Binding Proteins in Escherichia coli and ACCEPTED

Simple Model for the Study of Pseudomonas aeruginosa Infections in Leukopenic Mice

Pathogenicity of Infectious Diseases

Evaluation of Type-Specific and Non-Type-Specific Pseudomonas Vaccine for Treatment of Pseudomonas Sepsis During Granulocytopenia

PD Targets for Various Infection Types: Stasis vs. 1-Log Kill vs. 2 Log Kill

INTRABULBAR INOCULATION OF JAPANESE ENCEPHALITIS VIRUS TO MICE

An Attempt to Establish Experimental Dysenteric Bacilli Cystitis

Adenium Biotech. Management: - Peter Nordkild, MD, CEO, ex Novo Nordisk, Ferring, Egalet - Søren Neve, PhD, project director, ex Lundbeck, Novozymes

URINARY TRACT INFECTIONS IN DIABETIC PATIENTS ATTENDING OUTPATIENT DEPARTMENTS AT KASTURBA MEDICAL COLLEGE TEACHING HOSPITAL, MANIPAL, INDIA

320 MBIO Microbial Diagnosis. Aljawharah F. Alabbad Noorah A. Alkubaisi 2017

Cefotaxime Rationale for the EUCAST clinical breakpoints, version th September 2010

Animal Models to Understand Immunity

Effect of various solvents on bacterial growth in context of determining MIC of various antimicrobials

Effect of various solvents on bacterial growth in context of determining MIC of various antimicrobials

Effect of glucose and ph on uropathogenic and non-uropathogenic Escherichia coli: studies with urine from diabetic and non-diabetic individuals

Biofilms: Álvaro Pascual MD, PhD Department of Microbiology

Reduction of Population Levels of Some Indigenous Bacteria by Lactobacilli in the Gastrointestinal Tract of Gnotobiotic Rats

Antimicrobial Effects of Vinegar. Daniel Crawford Grade 9 Central Catholic High School

Ceftomax TM S (Cefoperazone Sodium plus Sulbactam Sodium Injection)

NEOSPORIN G.U. Irrigant Sterile (neomycin sulfate polymyxin B sulfate solution for irrigation)

Host Parasite Relationship. Prof. Hanan Habib Department of Pathology, College of Medicine,KSU

EXPERIMENTAL SHIGELLA INFECTIONS: CHARACTERISTICS OF A FATAL

Lab 4. Blood Culture (Media) MIC AMAL-NORA-ALJAWHARA 1

Association of C-reactive Protein and Circulating Leukocytes with Resistance to Staphylococcus aureus Infection in Endotoxin-treated Mice and Rabbits1

Antibiotic Usage Related to Microorganisms Pattern and MIC

Cyclophosphamide. was withdrawn by a needle and syringe, and the. samples were plated in molten agar. At the time of

Bacterial Mechanisms of Pathogenicity. 2 nd Lecture

BACTERIAL PATHOGENESIS

ABIMMUNE Repurposing disused antibiotics with immune modulators as antimicrobial strategy for respiratory tract infections

COAGULATION OF HUMAN PLASMA BY PASTEURELLA PESTIS'

Evaluation of Antibacterial Effect of Odor Eliminating Compounds

Supplemental Information. Gut Microbiota Promotes Hematopoiesis to Control Bacterial Infection. Cell Host & Microbe, Volume 15

New Zealand Data Sheet COLISTIN-LINK

Gram Positive Coccus Staphylococci Dr. Hala Al Daghistani

Cubicin A Guide to Dosing

Antibacterial Effect of Pulsatilla chinensis towards Staphylococcus aureus, Shigella dysenteriae, and Salmonella typhi

Against Aerobic Gram-Negative Bacilli

RELATIONSHIP TO RESISTANCE IN KLEBSIELLA PNEUMONIAE

Bacterial Interference in Chick Embryos *

usually contain somatic protein as the principal antigen, determination of the Heidelberger and Kendall (1932) developed a method for the quantitative

In vitro and Intracellular Activities of Peptide Deformylase. Inhibitor GSK against Legionella pneumophila Isolates

Sensitivity of Gram-negative bacilli to ampicillin

(multidrug-resistant Pseudomonas aeruginosa; MDRP)

Consultation on the Revision of Carbapenem Breakpoints

Alginate Inhibition of the Uptake of Pseudomonas aeruginosa by Macrophages

Sputum Screening by Nomarski Interference Contrast

The First Department of Bacteriology and Department of Tuberculosis, National Institute of Health, Kamiosaki, Shinagawa-ku, Tokyo 141

Natural History of Aortic Valve Endocarditis in Rats

P. A. AKPAN AND J. T. ABRAHAM

SOME PROPERTIES OF ECHO AND COXSACKIE VIRUSES IN TISSUE CULTURE AND VARIATIONS BY HEAT

NEONATAL SEPSIS. Dalima Ari Wahono Astrawinata Departemen Patologi Klinik, FKUI-RSCM

Diabetes and Host Resistance

Asian Journal of Pharmaceutical Analysis and Medicinal Chemistry Journal home page:

PATHOGENICITY OF MICROORGANISMS

Ceftizoxime in the treatment of infections in patients with cancer

Effect of Vaccine, Route, and Schedule on Antibody

Hydrogen Peroxide Influence on Microbial Survivorship. Jacob Cebulak Central Catholic Pittsburgh Grade 9

BY ZACHARY MODISPACHER 11 TH GRADE CENTRAL CATHOLIC HIGH SCHOOL

Immunologically Induced and Elicited Local

LD 60 determinations.-in order to study the resistance of mice to H. RESISTANCE INDUCED AGAINST HISTOPLASMA CAPSULA TUM: QUANTITATIVE ASPECTS*

Comparison of Colistin-Carbenicillin, Colistin,

Bacteraemia in patients receiving human cadaveric

PRODUCT INFORMATION. Colistin Link. Colistin 150 mg/2 ml (as colistimethate sodium) powder for injection vial

Below is an overview of the oral and poster presentations featuring cefiderocol and S at IDWeek 2017:

UTI IN ELDERLY. Zeinab Naderpour

Foundations in Microbiology

Medical Bacteriology Lecture 15

Enhanced EARS-Net Surveillance 2017 First Half

The Clinical Significance of Blood Cultures. Presented BY; Cindy Winfrey, MSN, RN, CIC, DON- LTC TM, VA- BC TM

Experiment #1 TARGET Mouse Model Group. Report prepared by Paul Converse, Ph.D. and Eric Nuermberger, M.D. March 1, 2006

Pathogenesis of Infectious Diseases. CLS 212: Medical Microbiology

Received 30 March 2005; returned 16 June 2005; revised 8 September 2005; accepted 12 September 2005

IMMUNOACTIVE PEPTIDES, FK-156 AND FK-565. II

Bacterial Infections of the Urinary System *

ROLE OF HYALURONIDASE AND THE HYALURONIC ACID CAPSULE IN

Activity of Ceftolozane/Tazobactam Against a Broad Spectrum of Recent Clinical Anaerobic Isolates

ANTIBACTERIAL ACTIVITY OF GYMNEMA SYLVESTRE HYDROALCOHOLIC LEAF EXTRACT.

Clinical Comparison of Cefotaxime with Gentamicin plus Clindamycin in the Treatment of Peritonitis and Other Soft-Tissue Infections

Gram-negative rods Ferment glucose with acid production Reduce nitrates into nitrites Oxidase negative Facultative anaerobic

Guillain-Barré Syndrome

Treatment of febrile neutropenia in patients with neoplasia

Quantitation of Microorganisms in Sputum

Investigating the Potential of Escherichia coli to Promote Kidney Stone Formation

Discrepancies in the recovery of bacteria from multiple sinuses in acute and chronic sinusitis

Biological Consulting Services

Enhanced EARS-Net Surveillance REPORT FOR 2012 DATA

Randomized Prospective Study Comparing Moxalactam and Cefoxitin with or without Tobramycin for the Treatment of Serious Surgical Infections

1. Effect of Temperature on Antibacterial Activity of Honey

Pharmacologyonline 1: (2010) ewsletter Singh and Kochbar. Optimizing Pharmacokinetic/Pharmacodynamics Principles & Role of

Comparative Activity of Cefotaxime and Selected f3-lactam Antibiotics Against Haemophilus Influenzae and Aerobic Gram-Negative Bacilli

Transcription:

Leukopenic and Lethal Effects of Slime from Acinetobacter calcoaceticus Yoshiki OBANA and Takeshi NISHINO Department of Microbiology, Kyoto Pharmaceutical University Key words: A.calcoaceticus, slime, leukopenia, lethal effect Abstract Intravenous and intraperitoneal injections of slime from Acinetobacter calcoaceticus TMS266 induced leukopenia and death in. The leukopenia was characterized by a decrease in neutrophil count, followed by death of. This decrease of leukocytes was profound and supposed to contribute to the enhancement of virulence of other bacteria such as Escherichia coli. In treated with sublethal doses of the slime, the slime could not show its capacity to reduce circulating leukocytes. Introduction Acinetobacter calcoaceticus has been isolated from patients with urinary tract infectionsu, pneumonia2), or septicemia3). Although Acinetobacter calcoaceticus infections have been studied in recent years, relatively little is known about the pathogenesis concerned4)5). Previous studies concerning the pathogenicity of Acinetobacter calcoaceticus have confirmed the role of slime of this bacterial species6)7). It has been demonstrated that the slime produces antiphagocytic and lethal effects in. In this study, the slime-induced leukopenic and lethal effects were further characterized. Materials and Methods Organism. Acinetobacter calcoaceticus TMS266, originally isolated from a human clinical specimen, was supplied by Prof. S. Goto (School of Medicine, Toho University, Tokyo). Bacterial slime. Slime was obtained from the strain as indicated and was purified by methods described previously6). Slime was extracted with saline from 48-hours bacterial cultures grown on sheets of cellophane overlying brain heart infusion agar (Difco). The crude slime was precipitated with cold ethanol. After treatment with chloroform-i-amylalcohol, 0.1 N sodium hydroxide, and cethylpyridinium chloride, in that order, the purified slime was obtained. Chemical components of the slime were determined by methods described previously6). The slime had high contents of sugar, protein, and orcinol reaction-positive substances. Animals. Four-week-old male of ddy strain weighing 17 to 18g were used and were supplied with water and laboratory chow ad libitum. Animal challenge. Groups of ten were injected intravenously or intraperitoneally with 0.2ml of twofold dilutions of the slime. Animals were observed daily for up to five days and the LD50 value was estimated by the Probit method. Leukocyte counts. Leukocyte counts were made on peripheral blood samples collected retroorbitally. The results are presented in terms of average of five per group. Results Toxicity of slime. The toxicity of slime in is shown in Table 1. The slime extracted from Acinetobacter calcoaceticus TMS266 showed high toxic effect when it was injected intravenously and intraperitoneally into. The LD50 values for intravenous and intraperitoneal injections were 0.019

Table 1 Lethal activity of slime from Acinetobacter calcoaceticus TMS266 a) 100 Ž, 15min. b) not done Fig. 1 Leukopenia in the peripheral circulation of normal after intraperitoneal injection of slime from Acinetobacter calcoaceticus TMS266 Fig. 2 Leukopenia in the peripheral circulation of slime-treated after intraperitoneal injection of slime from Acinetobacter calcoaceticus TMS266 mg/mouse and 0.062 mg/mouse, respectively. Heating to 100 Ž for 15 min did not alter the ability of the slime to induce lethality in. Effect of slime on blood leukocyte counts. The leukocyte counts were determined on blood samples obtained at various time intervals after intraperitoneal injection of slime (Figure 1). Whereas salineinjected showed little, if any, change in total leukocyte count, receiving slime were found to undergo rapid, pronounced, and sustained leukopenia in the peripheral blood, followed by death. The leukopenia was due mainly to a decrease in the number of circulating polymorphonuclear leukocytes. Similar experiments were performed with treated with 0.04 mg/mouse of slime eight and four days before the experiment. The result indicates that the slime could not show its capacity to reduce circulating leukocytes in treated (Figure 2). Virulence-enhancing activity of slime. The effect of slime on the virulence of Escherichia coli ST0198 in

Table 2 Effect of slime from Acinetobacter calcoaceticus TMS266 on the virulence of Escherichia coli ST0198 in normal and slime-treated Fig. 3 Effect of slime from Acinetobacter calcoaceticus TMS266 after intraperitoneal injection into normal and slime-treated infected with Escherichia coli ST0198 n=5 Normal n=5 Slime-treated Eight were used for each group in this experiment. Hours after inoculation is shown in Table 2. For normal, whereas the LD50 value of Escherichia coli was 2.2 ~106 cells/mouse in control, the LD50 values for receiving 0.02mg and 0.04mg of slime were 2.2 ~105 cells/mouse and 2.2 ~10cells/mouse, respectively. Mice receiving slime was 10-to 105-fold more susceptible than control. On the other hand, for treated with 0.04mg/mouse of slime eight and four days before experiment, no significant differences in LD50 could be detected between control and slime-receiving. The effect of 0.04 mg of slime on the bacterial counts in peripheral washings of infected intraperitoneally with Escherichia coli is shown in Figure 3. In normal, the bacterial counts of Escherichia coli in the control group showed a gradual decrease. However. in the slime receiving group an in bacterial count and subsequent death of the were observed during the 24-hours period after injection. In treated with 0.04mg/mouse of slime eight and four days before experiment, the counts in the control and slime-receiving groups showed a gradual decrease. The enhancement of the virulence of Escherichia coli was due mainly to a decrease in the number of circulating pol ymorphonuclear leukocytes, which play the most important role in acute infectious diseases. Discussion The present investigation studied the biological activities of slime from Acinetobacter calcoacetic Previous studies indicated that slime induces lethal and antiphagocytic effects in 6)7) In this study, the slime from Acinetobacter calcoaceticus TMS266 was highly toxic.. We observed that most of the given the slime died with haemorrhage in the thorax during the four -hour period after injection. Moreover, the lethal activity was retained after exposure to 100 Ž for 15 min. Therefore, the result suggests that the lethality might be due to heat-stable substances such as sugar component s et al. However, we observed lack of correlation between the lethality of viable cells and the toxicit y of the slime6). No experimentally supported explanation exists as yet. Lynn et al.8) and Dimitracopoulos et al.9) reported potent lethal activity of the slime of Pseudomonas aeruginosa in relati on to pathogenicity. In our study, we found that the slime of Acinetobacter calcoaceticus TMS266 was comparable to that of Pseudomonas aeruginosa in lethal activity for. We previously showed that Acinetobacter calcoaceticus slime interferes with polymorphonuclear leukocytes and macrophag es6)7). In this study, it was shown that the rapid and sustained leukopenia, induced by intraperitoneal injection of the slime, was characterized by a reduction in neutrophils. It seemed that the slime was able to induce the us.

leukopenia by quickly entering the blood from the peritoneal cavity. However, treatment with the slime protected from the leukopenia caused by injection of the homologous slime. The ability to maintain a large number of polymorphonuclear leukocytes in the circulating was an early indication that the would survive, whereas leukopenic usually died. No experimentally supported explanation is available as yet. Therefore, the enhancement of the virulence of other species was due mainly to a decrease in the number of circulating polymorphonulcear leukocytes. Lynn et al.8) and Dimitracopoulos et al.9) reported that the slime of Pseudomonas aeruginosa induces the leukopenia in. Furthermore, Schwarzmann et al.10), Laharrague et al.11), and Nadaud12) reported that the slime inhibits phagocytosis of neutrophils and macrophages. Johnson et al.13) also reported that the slime of Staphylococcus epidermidis interferes with granulocyte functions. The slime of Acinetobacter calcoaceticus was comparable to that of Pseudomonas aeruginosa and of Staphylococcus epidermidis in antiphagocytic activity. A substance like slime that induces leukopenia would constitute a virulence factor, whereas polymorphonuclear leukocytes and macrophages apparently play a key role in protection against several bacterial infections. Therefore, the results of this study support our previous conclusion6) that the slime is an important pathogenic product of Acinetobacter calcoaceticus cells. References 1) Pedersen, M. M., Marso, E. & Pickett, M. J.: Nonfermentative bacilli associated with man: III. Pathogenicity and antibiotic susceptibility. Amer. J. Clin. Path. 54: 178-192, 1970. 2) Wands, J. R., Mann, R. B., Jackson, D. & Butler, T.: Fatal community-acquired Herella pneumonia in chronic renal disease. Amer. Rev. Resp. Dis. 108: 964-967, 1973. 3) Richardson, R. I.: Mimeae septicemia. J. Amer. Med. Assoc. 207: 1716-1717, 1969. 4) Kuck,N. A.: In vitro and in vivo activities of minocycline and other antibiotics against Acinetobacter(Herella-Mima). Antimicrob. Agents Chemother. 9: 493-497, 1976. 5) Obana, Y., Nishino, T. & Tanino, T.: In-vitro and in-vivo activities of antimicrobial agents against Acinetobacter calcoaceticus. J. Antimicrob. Chemother. 15: 441-448, 1985. 6) Obana, Y.: Pathogenic significance of Acinetobacter calcoaceticus: Analysis of experimental infection in. Microbiol. Immunol. 30: 645-657, 1986. 7) Obana, Y., Nishino, T. & Tanino, T.: Effect of the slime from Acinetobacter calcoaceticus on the function of phagocytic cells. J. Jpn. Assoc. Infect. Dis. 59: 580-587, 1987. 8) Lynn, M., Sensakovic, J. W. & Bartell, P. F.: In vivo distribution of Pseudomonas aeruginosa slime glycolipoprotein: Association with leukocytes. Infect. Immun. 15: 109-114, 1977. 9) Dimitracopoulos, G. & Bartell, P. F.: Slime glycolipoprotein and the pathogenicity of various strains of Pseudomonas aeruginosa in experimental infection. Infect. Immun. 30: 402-408, 1980. 10) Schwarzmann, S. & Boring, J. R. III.: Antiphagocytic effect of slime from a mucoid strain of Pseudomonas aeruginosa. Infect. Immun. 3: 762-767, 1971. 11) Laharrague, P. E., Corberand, J. X., Fillola, G., Gleizes, B. J., Fontanilles, A. M. & Gyrard, E.: In vitro effect of the slime of Pseudomonas aeruginosa on the function of human polymorphonuclear neutrophils. Infect. Immun. 44: 760-762, 1984. 12) Nadaud, M.: Effects of a glycopolypeptide from the slime of P. aeruginosa on phagocytosis by mouse macrophages. Zbl. Bakt. Hyg., I Abt. Orig. A254: 489-499, 1983. 13) Johnson, G. M., Lee, D. A., Regelmann, W. E., Gray, E. D., Peters, G. & Quie, P. G.: Interference with granulocyte function by Staphylococcus epidermidis slime. Infect. Immun. 54: 13-20, 1986.

Acinetobacter calcoaceticus Acinetobacter calcoaceticus Escherichia coli